Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA OTC office, national uniformity in pending amendment to Senate FDA reform bill.

This article was originally published in The Tan Sheet

Executive Summary

FDA OTC OFFICE WOULD BE CREATED UNDER FDA REFORM BILL AMENDMENT pending introduction by Sen. Judd Gregg (R-N.H.) to Labor & Human Resources Committee Chairman James Jeffords' (R-Vt.) FDA reform legislation (S 830). During a June 11 mark-up of the "Food and Drug Administration Modernization Act of 1997," which was dedicated to opening statements by Senate Labor Committee members and a brief discussion of "non-controversial" topics related to the bill, Gregg's proposed establishment of an OTC office was one of 68 "pending" amendments set aside for possible debate when the mark-up resumes.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087171

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel